Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Higher levels of certain proteins may increase or decrease rosacea risk.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Gloriosa superba poisoning can mimic severe tropical infections and cause rapid hair loss.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Long-COVID has diverse, long-term health impacts, especially in young people.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

Many women with seborrheic dermatitis also have acne and diabetes, and should be checked for these conditions to help improve their quality of life.

Severe COVID-19 increases the risk of hair loss.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The hydrogel helps wounds heal better by reducing inflammation and promoting skin regeneration.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Hair microscopy is a simple and cost-effective method to help diagnose systemic diseases in children.

Undiagnosed lupus can cause severe complications after epidural anesthesia, leading to muscle weakness and potentially death.

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.

COVID-19 may trigger hair loss conditions like alopecia areata.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.